The incidence of the gene for thermolabile methylene tetrahydrofolate reductase in African Americans

Thrombosis Research

Volumn 83, Issue 2, 1996, Pages 195-198

  McAndrew, Patricia E ^b   Brandt, John T ^b   Pearl, Dennis K ^a   Prior, Thomas W ^b  

^a Depts of Pathology and Statistics   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

homocysteine; thrombophilia; thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; ENZYME ISOLATION; GENE ISOLATION; GENETIC POLYMORPHISM; HOMOCYSTINURIA; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; TEMPERATURE SENSITIVITY;

EID: 0005775025     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00121-1     Document Type: Short Survey

References (14)

1. 1. REES, M.M. and RODGERS, G.M. Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb. Res. 71, 337-359. 1993.
2. 2. BOUSHEY, C.J., BERESFORD, S.A.A., OMENN, G.S. and MOTULSKY, A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. J.A.M.A. 274, 1049-1057, 1995.
3. 3. GIBSON, J.B., CARSON, N.A.J. and NEIL, D.W. Pathologic findings in homocystinuria. J. Clin. Pathol. 77, 427-437, 1964.
4. 4. MCCULLY, K.S. Vascular pathology of homocysteinemia. Am. J. Pathol. 56, 111-128, 1969.
5. 5. WILCKEN, D.E.L. and WILCKEN, B. The pathogenesis of coronary artery disease: a possible role for methionine metabolism. J. Clin. Invest. 57, 1079-1082, 1976
6. 6. FROSST, P., BLOM, H.J., MILOS, R., GOYETTE, P., SHEPPARD, C.A., MATTHEWS, R.G., BOERS, G.J.H., DEN HEIJER, M., KLUIJTMANS, L.A.J., VAN DEN HEUVEL, L.P. and ROZEN, R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics 10, 111-113, 1995.
7. 7. MILLER, S.A., DYKES, D.D. AND POLESKY, H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 16, 1215, 1988.
8. 8. KANG, S.-S., WONG, P.W.K., SUSMANO, A., SORA, J., NORUSIS, M. and RUGGIE, N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am. J. Hum. Genet. 48, 536-545, 1991.
9. 9. BERTINA, R.M., KOELEMAN, B., P.C., KOSTER, T., ROSENDAAL F.R., DIRVEN, R.J., DE RONDE, H., VAN DER VELDEN, P.A. and REITSMA, P.H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369, 64-67, 1994.
10. 10. DAHLBÄCK, B. Inherited thrombophilia: resistance to activated protien C as a pathogenic factor of venous thromboembolism. Blood 85, 607-614, 1995.
11. 11. REES, D.C., COX, M. and CLEGG, J.B. World distribution of factor V Leiden. Lancet 346, 1133-1134, 1995.
12. 12. HOOPER, W.C., DlLLEY, A., RENSHAW, M., BENSON, J., AUSTIN, H., SILVA, V., RAWLINS, P., WENGER, N.K. and EVATT, B.L. The prevalence of genetic markers associated with vascular disease in African-Americans. Blood 86, 204a, 1995 (abstract).
13. 13. GOLDHABER, S.Z. and MORPURGO, M. Diagnosis, treatment and prevention of pulmonary embolism: report of the WHO/International Society and Federation of Cardiology Task Force. J.A.M.A. 268, 1727-1733, 1992.
14. 14. KNIFFIN, W.D., BARON, J.A., BARRETT, J., BIRKMEYER, J.D. and ANDERSON, F. A. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch. Intern. Med. 154: 861-866, 1994.